DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications

I González-Ramírez1, C García-Cuellar, Y Sánchez-Pérez

  • 1Instituto Nacional de Cancerología, Subdirección de Investigación Básica, México City, México. zoegon14@hotmail.com

Oral Diseases
|July 26, 2011
PubMed

Insights

DNA methylation, an epigenetic change, silences tumor suppressor genes. Promoter methylation is key in oral squamous cell carcinoma (OSCC) development, impacting cell cycle, DNA repair, and apoptosis.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • DNA methylation is a key epigenetic mechanism regulating gene transcription.
  • Aberrant DNA methylation, particularly promoter methylation, is implicated in various cancers.
  • Oral squamous cell carcinoma (OSCC) development involves genetic and epigenetic alterations.

Purpose of the Study:

  • To review the current understanding of promoter methylation in oral squamous cell carcinoma.
  • To highlight the role of methylated tumor suppressor genes in OSCC carcinogenesis.
  • To identify frequently methylated genes involved in critical cellular processes in OSCC.

Main Methods:

  • Literature review of studies on DNA methylation in OSCC.
  • Analysis of gene promoter methylation patterns in oral cancer tissues.
  • Correlation of methylation status with gene silencing and tumor development.

Main Results:

  • Promoter methylation of tumor suppressor genes is a significant factor in OSCC development.
  • Methylation frequently affects genes regulating cell cycle, DNA repair, proliferation, and apoptosis in OSCC.
  • These epigenetic changes contribute to the multistep process of oral carcinogenesis.

Conclusions:

  • Promoter methylation of specific genes is a crucial epigenetic event in oral squamous cell carcinoma.
  • Understanding these methylation patterns can offer insights into OSCC pathogenesis.
  • Targeting these epigenetic alterations may hold therapeutic potential for OSCC.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...